Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. [electronic resource]
- Nature genetics May 2011
- 482-6 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1546-1718
10.1038/ng.811 doi
Animals Antitubercular Agents--pharmacology Base Sequence DNA, Bacterial--genetics Disease Models, Animal Drug Resistance, Bacterial--genetics Genome, Bacterial Humans Isoniazid--pharmacology Latent Tuberculosis--drug therapy Macaca fascicularis Models, Genetic Mutation Mycobacterium tuberculosis--drug effects Polymorphism, Single Nucleotide Time Factors Tuberculosis, Multidrug-Resistant--drug therapy